Full-Time

Health Outcomes Data Scientist

Posted on 8/15/2025

Arine

Arine

201-500 employees

Data-driven medication management for providers

Compensation Overview

$135k - $160k/yr

Remote in USA

Hybrid

Remote role in the United States; occasional on-site meetings required several times per year.

Category
Data & Analytics (1)
Required Skills
Python
Data Science
R
SQL
Machine Learning
Data Analysis
Requirements
  • Bachelor’s degree in Healthcare Outcomes, Healthcare Economics, Statistics, Epidemiology, Computer Science, Statistics, Physical Sciences, or related field (advanced degree preferred)
  • Meaningful experience (3+ years) working with healthcare data (e.g., medical and pharmacy claims data)
  • Experience manipulating data frames, conducting analyses, and creating graphics with Python, R and SQL
  • Significant hands-on experience estimating statistical models and knowledge of causal inference methodologies using real-world data (e.g., difference-in-difference regression, matching)
  • Experience working cross-functionally to define analyses objectives and deliver analytical results
  • Demonstrated ability to work independently, exercise good judgment, prioritize multiple projects, and problem-solve under tight deadlines and resource constraints
  • Excellent written, interpersonal communication, and presentation skills, including the ability to present complex technical concepts in a clear, concise manner to audiences with varying levels of technical understanding
  • Ability to pass a background check
  • Must live in and be eligible to work in the United States
  • Remote Work Requirements: An established private work area that ensures information privacy; A stable high-speed internet connection for remote work; This role is remote, but you will be required to come to on-site meetings multiple times per year.
Responsibilities
  • Use Python, R, and/or SQL and advanced statistical methods to assess the impact of Arine’s programs rigorously
  • Create presentations and reports to communicate updates to the Data Science team, as well as to cross-functional stakeholders
  • Participate in critical reviews within the Data Science team on everything from methods used to implementation strategy and code
  • Perform ad-hoc analyses to satisfy customer inquiries and reporting

Arine provides a data-driven platform for medication management in healthcare. It analyzes patient health data to offer personalized MTM, medication intelligence, and optimization through a subscription for providers, insurers, and health plans. The goal is to improve patient outcomes while reducing costs, by ensuring safe and effective medication use for older adults and those with complex regimens. It differentiates itself by focusing on personalized, evidence-based MTM and measurable care-quality improvements like CAHPS and Star ratings.

Company Size

201-500

Company Stage

Series C

Total Funding

$70M

Headquarters

San Francisco, California

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Series C $30M from Town Hall Ventures expands specialty pharmacy AI in 2025.
  • Inc. 5000 recognition and 100% retention boost Star ratings for clients.
  • CMS MTM evolution favors Arine's automated reviews and real-time reporting.

What critics are saying

  • CoverMyMeds automates priors for 80M patients, erodes Arine's payer share.
  • CMS 2026 expands MTM to telepharmacy, slashing Priority Health retention.
  • Epic MyChart captures 70% hospital referrals, blocks Arine's provider pipeline.

What makes Arine unique

  • Arine merges AI with pharmacotherapy expertise for personalized MTM.
  • Platform analyzes claims, clinical, and SDOH data for precise interventions.
  • Delivers 40% hospitalization reduction and 10% cost savings across 30M lives.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Professional Development Budget

Company News

FinSMEs
Jun 24th, 2025
Arine Raises $30M in Series C Funding

Arine, a San Francisco, CA-based AI-driven medication intelligence company, raised $30M in Series C funding.

StreetInsider
Jun 24th, 2025
Arine Secures $30M for AI Medication Optimization

Arine, a leader in AI-driven medication optimization, announced a $30 million Series C funding round led by Town Hall Ventures, with participation from Kaiser Permanente Ventures. This brings Arine's total funding to $66 million. The funds will help Arine expand its platform's capabilities, focusing on specialty pharmacy management and AI innovation to enhance patient care and cost savings. Arine has achieved over 10% cost savings and 40% reduction in hospitalizations.

PR Newswire
Jun 24th, 2025
Arine Raises Series C to Scale AI-Driven Medication Optimization and Power Value-Based Outcomes

/PRNewswire/ -- Today Arine, the leader in AI-driven medication intelligence, announced a Series C funding round. Town Hall Ventures, known for backing...

HIT Consultant
Jun 24th, 2025
Arine Raises $30M to Redefine Medication Management with AI

- Arine, the leader in AI-driven medication intelligence announced it has closed a $30M Series C funding round led by Town Hall Ventures, with participation from Kaiser Permanente Ventures and other existing investors.

HIT Consultant
Jan 15th, 2025
Overprescribing And Polypharmacy: Arine Ceo Talks The Hidden Dangers Of Amazon’S Same-Day Prescription Delivery

Yoona Kim, Founder CEO at ArineAs ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high.In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may inadvertently contribute to dangerous polypharmacy and medication mismanagement. She comments on the critical challenges facing healthcare providers, from fragmented medication tracking to rapidly evolving drug knowledge, and explores how AI-powered solutions can help ensure safe, effective medication management in an increasingly automated healthcare landscape.What are the potential benefits and risks of ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery? How can these services impact patient access to medications and adherence to treatment plans?Yoona Kim, Founder CEO at Arine: Ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery offer clear benefits to patients, particularly those with acute health needs. Instead of having to pick up medication from the pharmacy – while potentially feeling under the weather – patients can have medications delivered straight to their door within hours. It’s easy to see why this level of convenience is appealing, especially as we grow accustomed to rapid delivery in other areas of our lives, such as grocery shopping.However, this convenience comes with considerable risks in our already fragmented healthcare ecosystem. To start, it complicates providers’ ability to track a patient’s medications

INACTIVE